tissue plasminogen activator

1. Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
   重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
2. Comparison of thrombolytic therapy with recombinant tissue plasminogen activator and urokinase for acute myocardial infarction;
   目的探讨静脉溶栓对男女急性心肌梗塞患者的疗效对比。
3. Expression levels of tissue plasminogen activator and plasminogen activator inhibitor in endometrium of patients with symptomatic uterine leiomyomas
   症状性子宫肌瘤患者子宫内膜中tPA、PAI的表达
4. The Initial Research about the Effect of Tissue Plasminogen Activator on Neural Repair
   组织纤溶酶原激活物对神经修复影响的初步探讨
5. Study on tissue plasminogen activator change in recurrence of stroke patients The blindness was secondary to embolic infarction of both occipital lobes developing as a sequela of IE.
   血纤溶活性变化对缺血性脑梗死复发的影响眼盲次发于两侧脑枕叶血栓性梗塞，为感染性心内膜炎的并发症。
6. The screening of human tissue plasminogen activator recombinant plasmid showed that the two methods can recognize the positive colones quickly and correctly.
   测序结果表明这两种方法能快速，准确地筛选出阳性克隆。
7. Correlation between Blood Glucose Level and Prognosis and Risk of Intracerebral Hemorrhage after Intravenous Recombinant Tissue Plasminogen Activator Thrapy for Acute Ischemic Stroke Cholesterol levels and ischemic stroke of symptomatic hemorrhagic transformation after thrombolytic therapy
   血糖与rt-PA治疗急性脑梗死的预后及出血转化相关性研究缺血性卒中溶栓后症状性出血转化相关因素分析
8. Expressions of Survivin and uPA in human cerebral gliomas Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
   脑胶质瘤组织中Survivin和尿激酶型纤溶酶原激活物蛋白的表达重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
9. Lysis of the hematoma with various enzymes, such as urokinase or tissue plasminogen activator ( TPA), and drainage of liquefied clot has become an alternative.
   因而，应用不同的酶如尿激酶或组织纤维蛋白溶酶原激活剂来溶解血肿和引流液化的血凝块，成为可供选择的治疗方法。
10. Objective To further recognize the differences of efficacy and safety of intravenous thrombolysis with recombinant tissue plasminogen activator ( rt-PA) vs urokinase ( UK) in treatment of acute myocardial infarction ( AMI).
    目的进一步认识重组组织型纤溶酶原激活剂（rtPA）与尿激酶（UK）静脉溶栓治疗急性心肌梗死（AMI）疗效和安全性的差异。
11. [ Methods] The serum concentration of blood-fat and the plasmatic activities of tissue plasminogen activator ( t-PA) and PAI-1 were determined in 91 patients with ACI and 40 healthy old people.
    方法测定了91例ACI患者和40例健康老年人的血脂浓度和血浆t-PA和PAI-1活性；
12. The effect of recombinant human tissue plasminogen activator on coagulation function and immune response in pigs
    重组人类组织型纤溶酶原激活剂对家猪凝血和免疫指标的影响
13. Tissue plasminogen activator ( t-PA) and plasminogen activator inhibitor-1 ( PAI-1) activity were measured with chromogenix;
    发色底物法检测内皮细胞培养液中的组织纤溶酶原激活物（t-PA）和纤溶酶原激活物抑制剂（PAI-1）的活性；
14. Objective To discuss the efficiency and safety of recombinant tissue plasminogen activator ( rt-PA) for patients with acute cerebral infarction.
    目的探讨重组组织型纤溶酶原激活剂（rt-PA）治疗急性脑梗死的有效性和安全性。
15. Objective To investigate the effect of recombinant human tissue plasminogen activator ( rtPA) on coagulation function and immune response in pigs.
    目的了解重组人类组织型纤溶酶原激活剂（rtPA）对家猪的凝血功能和免疫反应的影响。
16. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke
    重组型组织纤溶酶原激活剂治疗急性缺血性卒中后的止血激活和临床预后
17. Objective To evaluate the effects of ultrasound irradiation on tissue plasminogen activator ( TPA) fibrinolysis in vitro.
    目的评价在体外实验条件下，超声波辐照对组织型纤溶酶原激活物（TPA）溶栓效率的促进作用。
18. Objective: To investigate the effect of leech injection on thrombosis and plasma tissue plasminogen activator ( t PA) and its inhibitor ( PAI) in the thrombosis model of mice.
    目的：研究水蛭注射液对小鼠体内血栓形成和血浆纤溶酶原激活物（tPA）及抑制物（PAI）的影响。
19. The Changes of Plasma Tissue Plasminogen Activator and its Inhibitor Activity and Collagen Turnover during Vascular Restenosis Development
    血管再狭窄发生过程中血浆组织型纤溶酶原激活物及其抑制剂活性与胶原转换的变化
20. Regulation of tissue plasminogen activator expression by EGF in epidermal keratinocytes of mouse
    EGF对小鼠角质形成细胞中组织型纤溶酶原激活剂表达的调节
21. The thrombolytic effect was compared between urokinase ( UK) and human tissue plasminogen activator ( t-PA) in rabbits with experimental iliofemoral artery thrombus.
    本文用尿激酶（UK）和人体组织型纤溶酶原激活剂（t-PA）进行了兔髂股动脉血栓实验性溶解的对照研究。
22. Objective To explore the regulation of calcium on the expression of tissue plasminogen activator ( tPA) and its relationship with cell differentiation in mouse epidermal keratinocyte ( KC).
    目的探讨小鼠表皮角质形成细胞（KC）中Ca~（2＋）对组织型纤溶酶原激活剂（tPA）表达的调节作用及其与分化的关系。
23. Objective To study the changes in tissue plasminogen activator ( t-PA) and inhibitor-1 ( PAI-1) expression in pulmonary artery after acute pulmonary thromboembolism ( PTE).
    目的通过研究兔实验性肺血栓栓塞（PTE）后组织型纤溶酶原激活物（t-PA）及其抑制物-1（PAI-1）在肺动脉中表达的动态变化，了解急性肺栓塞后机体纤溶能力的变化。
24. Analysis of Recombinant Human Tissue Plasminogen Activator and Its Mutants
    重组人组织纤维蛋白溶酶原激活剂及突变体的分析
25. Objective It is to study the effect of Scorpion Venom Fibrinolytic Active Peptide ( SVFAP) on vein endothelial cell releasing tissue plasminogen activator ( t-PA) and plasminogen activator inhibitor-1 ( PAI-1).
    目的研究蝎毒纤溶活性肽（SVFAP）对血管内皮细胞释放组织型纤溶酶原激活剂（t-PA）和纤溶酶原激活剂抑制物（PAI-1）的影响。
26. Erythrina trypsin inhibitor ( ETI), which belongs to serine proteinase inhibitor, has the ability to inhibit trypsin and tissue plasminogen activator.
    刺桐胰蛋白酶抑制剂（ETI）属于丝氨酸蛋白酶抑制剂，它能和胰蛋白酶及瑞替普酶（r-PA）等精氨酸特征性的丝氨酸蛋白酶发生可逆亲合作用。
27. Objective To establish a cell line stably expressing the tissue plasminogen activator ( TPA) inhuman skin fibroblasts so as to develop the function analysis and gene therapy of TPA in ischemic heart diseases.
    目的：建立在人皮肤成纤维细胞中稳定表达的细胞株，为组织型纤溶酶原激活因子（TPA）功能分析和对缺血性心脏疾病基因治疗提供理论依据。
28. Effects of tissue plasminogen activator ( t-PA) on scar formation after experimental filtration surgery
    组织型纤溶酶原激活剂（t-PA）对实验性青光眼滤过性手术瘢痕形成的影响
29. Objective To study the effect of the N pole and S pole of uneven constant magnetic field on tail thrombosis, plasma tissue plasminogen activator ( t-PA) and its inhibitor in mice.
    目的研究不均匀恒磁场N极和S极对小鼠尾部血栓形成和血浆组织型纤溶酶原激活物（t-PA）及其抑制物（PAI）的影响。

noun

1. a thrombolytic agent (trade name Activase) that causes fibrinolysis at the site of a blood clot

   Synonym:    Activase